ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

Study Needs 23,000 Women Whose Sisters Have Cancer

September 29, 2006

Funding opportunities listed.

October 29, 2004

Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions

December 13, 1985

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013